Four targets from $136 to $160 in 48 hours. With HOOD at $113.80 and the NFL here,...
Top News
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of...
A BOJ hike to 1.25% changes the currency math after the Nikkei's extraordinary run.
The Phase 3 win validated the platform. Now the harder work begins: manufacturing every dose from scratch.
Healthcare has outrun SOXX since June. The flows have barely started.
Tariff refunds made the quarter. The Q3 guide reveals the margin question.
The Jevons Paradox is alive in the GPU market. Falling token prices expand the addressable universe of...
A 20% post-earnings drop on record revenue is not a verdict on the business. It is a...
The China distribution reset mirrors the DTC pivot that hurt Nike in North America.
A 9-3 vote, a 3.4% CPI reading, and a September decision that will price every loan you...
